This study aims to evaluate the effects of craniosacral therapy on pain, body awareness, depression, and quality of life in primary caregivers of individuals with special needs.
Primary caregivers often experience physical and psychological burden due to long-term caregiving responsibilities. Craniosacral therapy is a non-pharmacological, manual therapy approach that may help reduce pain, improve body awareness, and support overall well-being.
In this study, eligible primary caregivers will be assigned to either a craniosacral therapy group or a control group. The intervention group will receive craniosacral therapy sessions, while the control group will receive no therapeutic intervention during the study period. Outcome measures related to pain, body awareness, depression, and quality of life will be assessed before and after the intervention.
The results of this study may contribute to a better understanding of the potential benefits of craniosacral therapy for improving the physical and psychosocial health of primary caregivers of individuals with special needs.
Female gender
Being a primary caregiver of an individual with special needs
Aged between 18 and 55 years
Caring for an individual who has a valid Special Needs Assessment Report for Children (ÇÖZGER) or a Health Board Report for Adults (ESKR)
Pregnancy
Presence of a neurological condition (e.g., epilepsy, acute cerebrovascular event)
Presence of tumors or metastatic disease
Unwillingness to participate in the study
Parallel
Craniosacral Therapy
Other interventionCraniosacral therapy is a non-pharmacological, manual therapy approach applied by a trained practitioner according to a standardized protocol.
Change in pain intensity measured by Short-Form McGill Pain Questionnaire (SF-MPQ) total score
Pain intensity will be assessed using the Short-Form McGill Pain Questionnaire (SF-MPQ). The total score is calculated from 15 descriptors (11 sensory, 4 affective), each rated from 0 (none) to 3 (severe). Higher scores indicate greater pain intensity. Total score (0-45)
Change in Body Awareness Questionnaire (BAQ) total score
Body awareness will be evaluated using the Body Awareness Questionnaire (BAQ), an 18-item self-report scale rated on a 7-point Likert scale. Total scores range from 18 to 126. Higher scores indicate greater body awareness. Total score (18-126).
Change in Beck Depression Inventory (BDI) total score
Depression severity will be measured using the Beck Depression Inventory (BDI), a 21-item self-report instrument. Each item is scored from 0 to 3. Total scores range from 0 to 63. Higher scores indicate greater depressive symptom severity. Total score (0-63).
Change in Adult Carer Quality of Life Questionnaire (AC-QoL) total score
Quality of life will be assessed using the Adult Carer Quality of Life Questionnaire (AC-QoL), a 40-item instrument covering eight domains related to caregiving. Total scores range from 0 to 120. Higher scores indicate better quality of life. Total score (0-120).
Change in systolic blood pressure (mmHg)
Systolic blood pressure will be measured using an automated digital sphygmomanometer (Omron® M2 Basic). Values are recorded in millimeters of mercury (mmHg).
Change in diastolic blood pressure (mmHg)
Diastolic blood pressure will be measured using an automated digital sphygmomanometer (Omron® M2 Basic). Values are recorded in mmHg.
Change in heart rate (beats per minute)
Heart rate will be measured using an automated digital sphygmomanometer. Values are recorded in beats per minute (bpm).
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
